TRIOS EasyMass: Unlocking Efficient Experiment Preparation with Automatic Mass Data Transfer
Overview Learn how to use the new TRIOS EasyMass featur…
Overview Learn how to use the new TRIOS EasyMass featur…
High-performance polymers are a critical material for manufacturers due to their combination of mechanical, thermal, and chemical properties, but especially their cost. Without adequate testing, manufacturers could run into a slew of issues, from immediate product failure to poor performance or failure after some time in usage.
The method of drug delivery significantly influences the final stages of the manufacturing process. Currently, lyophilization—a widely adopted technique—enables drug developers to stabilize formulations and therapeutic molecules using a validated commercial approach. In this process, precise control of pressure and temperature within a lyophilizer facilitates the removal of liquids from formulations containing thermally sensitive or hydrolytically unstable active pharmaceutical ingredients or formulation components.
Against the backdrop of a plastic waste crisis, the global demand for plastic is set to quadruple by 2060. This has driven a shift toward sustainability and away from linear use models of plastic production. Post-consumer resin (PCR) has emerged as a key player in circular economy initiatives, though ensuring the quality and performance of PCR requires several characterization considerations.
學術優勢計畫旨在讓學術機構能夠使用 TA Instruments 的高性能設備。我們十分重視我們的學術客戶,這些客戶不僅致力於開發新材料、新應用、出版物,最重要的是,他們還培養了才華洋溢的優異畢業生,將在未來工業上發光發熱。
As a central pillar of modern society, the pharmaceutical industry bears the load of billions of lives around the world. In 2022, the global revenue of the pharmaceutical industry approximated $1.5 trillion, a figure reflected in two decades of significant growth.
Overview TA Instruments – Waters Corporation’s state-of…
Overview In this Tech Tip, we will install the new Phot…
流變阻抗頻譜分析法可幫助人們深入了解如電池電極漿料、乳化液、漆料、塗料等複雜流體的微觀結構。將介電質阻抗頻譜分析與 DHR 的流變學測量相結合,使用者就能在攪拌、儲存和塗層等製程相關條件下,分析樣本微觀結構中剪切力引起的變化。
藥物開發是個漫長而複雜的過程,從探索開始,一直到讓政府批准上市才算成功。如下所述,藥物開發過程中的每個步驟都有特定的目標,旨在篩選出適合的活性化合物和候選原料,最終得到已核准的原料藥。
The RS-DSC is for preclinical development of antibodies, antibody-drug conjugates, and vaccines where dosage forms are typically greater than 50 µg.